Abstract

In this study 6 CTX-M positive E. coli isolates collected during a clinical study examining the effect of antibiotic use in a human trial were analysed. The aim of the study was to analyse these isolates and assess the effect of full or partial loss of plasmid genes on bacterial fitness and pathogenicity. A DNA array was utilised to assess resistance and virulence gene carriage. Plasmids were characterised by PCR-based replicon typing and addiction system multiplex PCR. A phenotypic array and insect virulence model were utilised to assess the effect of plasmid-loss in E. coli of a large multi-resistance plasmid. All six E. coli carrying bla CTX-M-14 were detected from a single participant and were identical by pulse field gel electrophoresis and MLST. Plasmid profiling and arrays indicated absence of a large multi-drug resistance (MDR) F-replicon plasmid carrying blaTEM, aadA4, strA, strB, dfrA17/19, sul1, and tetB from one isolate. Although this isolate partially retained the plasmid it showed altered fitness characteristics e.g. inability to respire in presence of antiseptics, similar to a plasmid-cured strain. However, unlike the plasmid-cured or plasmid harbouring strains, the survival rate for Galleria mellonella infected by the former strain was approximately 5-times lower, indicating other possible changes accompanying partial plasmid loss. In conclusion, our results demonstrated that an apparently healthy individual can harbour bla CTX-M-14 E. coli strains. In one such strain, isolated from the same individual, partial absence of a large MDR plasmid resulted in altered fitness and virulence characteristics, which may have implications in the ability of this strain to infect and any subsequent treatment.

Highlights

  • Cefotaximes are 3rd generation cephalosporins that are commonly used for treatment of enteric infections [1]

  • In the UK, the most prevalent CTX-M type in humans is blaCTX-M-15, which is present on a plasmid and associated with an Escherichia coli of multi-locus sequence type (MLST) ST131 [2]

  • PFGE analysis of all CTX-M-14 positive E. coli demonstrated they were indistinguishable by XbaIPFGE

Read more

Summary

Introduction

Cefotaximes are 3rd generation cephalosporins that are commonly used for treatment of enteric infections [1]. 137 variants of CTX-M genes have been described In the UK, the most prevalent CTX-M type in humans is blaCTX-M-15, which is present on a plasmid and associated with an Escherichia coli of multi-locus sequence type (MLST) ST131 [2]. Since its first detection the CTX-M-15 bearing E. coli ST131 has been found world-wide and is described as an epidemic strain. The group 9 gene blaCTX-M-14 is commonly detected in Spain, and its spread is associated with the dissemination of an IncK plasmid carrying blaCTX-M-14 [4]. Group 9 CTX-M enzymes constitute only 4% of the ESBL positive E. coli recovered from human clinical cases in the UK [5]. In the UK, blaCTX-M-14 has been detected in cattle and has been associated with an IncK plasmid [6]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.